Press Releases: National
May 13, 2011
Parental Exposure to BPA During Pregnancy Associated with Decreased Birth Weight in Offspring
OAKLAND Calif. — Parental exposure to bisphenol A (BPA) during pregnancy is associated with decreased birth weight of offspring, compared with offspring from families without parental BPA exposure in the workplace, according to Kaiser Permanente researchers.
The observational study is published in the current online issue Reproductive Toxicology.
Researchers explained that there was a greater magnitude of decrease in birth weight in children whose mothers were directly exposed to high BPA levels in the workplace during pregnancy, followed by those whose mothers were exposed to low levels of BPA in the workplace, then by those whose mothers had BPA exposure through the father’s high occupational BPA exposure, and finally, the least decrease in birth weight in the offspring whose mothers had BPA exposure through the father’s low occupational exposure.
Although the finding needs to be confirmed by additional studies, the study provides preliminary evidence that maternal exposure to BPA during pregnancy may have an adverse effect on fetal growth, said De-Kun Li, MD, PhD, the principal investigator of the study, senior author of the new publication, and a reproductive and perinatal epidemiologist at the Kaiser Permanente Division of Research in Oakland, Calif.
Exposure to BPA has been reported to reduce birth weight in animal studies at relatively high levels of exposure. Both animal and human studies have shown that BPA can pass through the placental barrier and that fetuses are likely to be exposed to similar (if not higher) levels of BPA as those of mothers, explained the researchers.
The study population was identified from a larger study of more than 1,000 male and female workers in factories in China. It compared workers in BPA-exposing facilities with a control group of workers in factories where no BPA was present. BPA-exposed (from the manufacturers of BPA and epoxy resin) and unexposed workers (from industries without BPA exposure), including their spouses and offspring, were recruited from 2003–2008.
Mothers in the mother-exposed group worked for at least three months during pregnancy. The researchers explained that it is possible that offspring in this group had relatively higher levels of in-utero BPA exposure than those in other groups. Spouses of exposed fathers, although not directly exposed to BPA in the workplace, were more likely to have a higher BPA exposure level than women in the unexposed group. Exposure in this group could occur through exposure to contaminated clothing, through workplace visits with spouses, and through residence proximity to factories, explained the researchers.
This study is the fourth in a series published by Dr. Li and his colleagues that examine the effect of BPA in humans. The first study, published in November 2009 in the Oxford Journals’ Human Reproduction, found that exposure to high levels of BPA in the workplace increases the risk of reduced sexual function in men. The second study, published in May 2010 in the Journal of Andrology, found that increasing BPA levels in urine are associated with worsening male sexual function. The third study, published in Fertility and Sterility, showed that an increasing urine BPA level was significantly associated with decreased sperm concentration, decreased total sperm count, decreased sperm vitality and decreased sperm motility.
Funded by the U.S. National Institute of Occupational Safety and Health, this latest study adds to emerging human evidence questioning the safety of BPA, a chemical created in the production of polycarbonated plastics and epoxy resins found in baby bottles, plastic containers, the linings of cans used for food and beverages, and in dental sealants.
The researchers explained that BPA is believed by some to be a highly suspect human endocrine disrupter, likely affecting both male and female reproductive systems. These findings provide epidemiological evidence that has been lacking as the U.S. Food and Drug Administration and various other U.S. government panels have explored this controversial topic.
The present study was limited by the small sample size in the exposed group. Due to the retrospective nature of the study, estimated exposure levels in the past, rather than maternal urine BPA level, was used to classify the exposure dosage during the index pregnancy. Although researchers have demonstrated that the estimated BPA exposure was correlated with current urine BPA, it is still possible that the association between BPA exposure and birth weight was impacted due to inaccurate classification of BPA exposure categories.
Other authors on this study include: J.R. Ferber, MPH, and L.J. Herrinton, PhD, of the Kaiser Permanente Division of Research; Z. Zhou, PhD, MD, and Y. He, PhD, of the Department of Occupational Health and Toxicology, School of Public Health and WHO Collaborating Center for Occupational Health, Fudan University, Shanghai, China; M. Miao, PhD, J. Wang, PhD, E. Gao, MD, MPH, PhD, and W. Yuan of Shanghai Institute of Planned Parenthood Research and National Population and Family Planning Key Laboratory of Contraceptive Drugs and Devices.
About the Kaiser Permanente Division of Research
The Kaiser Permanente Division of Research conducts, publishes and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well-being and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 400-plus staff is working on more than 250 epidemiological and health services research projects. For more information, visit www.dor.kaiser.org.
About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America’s leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 8.8 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: www.kp.org/newscenter.